TB Skin Test: Understanding This Diagnostic Tool

April 18, 2024

Back
Featured image for “TB Skin Test: Understanding This Diagnostic Tool”

Tuberculosis (TB) is a serious infectious disease that primarily affects the lungs but can also impact other parts of the body. Caused by the bacterium Mycobacterium tuberculosis, TB remains a significant global health concern. Early detection and treatment are crucial in controlling the spread of this disease. The TB skin test, also known as the Mantoux test or tuberculin skin test (TST), is a widely used diagnostic tool for identifying TB infection. This comprehensive article will provide an in-depth understanding of the TB skin test, its purpose, procedure, interpretation, and importance in the fight against tuberculosis.

As a healthcare provider with extensive experience in TB testing and management, I have witnessed firsthand the critical role that the TB skin test plays in diagnosing and controlling this infectious disease. By sharing my expertise and insights, I aim to empower readers with the knowledge they need to make informed decisions about their health and the health of their loved ones.

What is a TB Skin Test?

TB skin test, also known as the Mantoux test or PPD test (Purified Protein Derivative), is a diagnostic tool used to determine if a person has been infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). The test is an important part of TB diagnosis and public health measures to control the spread of this infectious disease.

The TB skin test works by measuring the immune system’s response to tuberculin, a purified protein derivative of the TB bacteria. When injected under the skin, tuberculin triggers a delayed-type hypersensitivity reaction in people who have been exposed to TB bacteria. This reaction causes a skin induration (hardening) at the injection site, which can be measured to determine the test result.

It’s important to note that the TB skin test is not a standalone diagnostic tool. It is used in conjunction with other methods, such as chest X-rayssputum culture, and TB blood tests (Interferon Gamma Release Assays or IGRAs), to diagnose active TB disease or latent TB infection (LTBI). While the TB skin test is widely used and relatively inexpensive, it has some limitations, such as the potential for false-positive results in people who have received the BCG vaccine or have been exposed to other non-tuberculosis mycobacteria.

As a healthcare provider with experience in TB testing and management, I understand the importance of accurate diagnosis and timely treatment of TB infections. The TB skin test remains a valuable tool in our efforts to control this global health threat, but it must be used judiciously and interpreted carefully in the context of each individual patient’s medical history and risk factors.

Who Needs a TB Skin Test?

A TB skin test is recommended for individuals who are at increased risk of TB exposure or developing active TB disease. Some common scenarios where a TB skin test may be needed include:

  1. Close contact with someone who has active TB disease: If you have spent time with a person who has been diagnosed with active TB, you should get tested to determine if you have been infected.
  2. Occupational exposure: Healthcare workers, prison staff, and other professionals who work in settings with a high prevalence of TB are often required to undergo regular TB testing.
  3. Travel to high-risk areas: If you have recently traveled to or lived in a country with a high incidence of TB, your doctor may recommend a TB skin test.
  4. Weakened immune system: People with HIV, diabetes, or other conditions that compromise the immune system are at higher risk of developing active TB if infected. Regular testing is often recommended for these individuals.
  5. Symptoms suggestive of TB: If you have a persistent cough, fever, night sweats, or unexplained weight loss, your doctor may order a TB skin test as part of the diagnostic workup.

As Dr. Sarah Thompson, a pulmonologist at City General Hospital, explains, “We consider a variety of factors when deciding who needs a TB skin test. In addition to the individual’s medical history and risk factors, we also look at the prevalence of TB in their community and the potential consequences of a missed diagnosis. Early detection and treatment of TB infections are critical to preventing the spread of this disease.”

Artboard 1 46

How is a TB Skin Test Performed?

The TB skin test is a two-visit procedure that involves the following steps:

  1. Injection: On the first visit, a healthcare professional will inject a small amount (0.1 mL) of tuberculin under the skin of your forearm. This injection is usually done on the inside of the forearm, about 2-4 inches below the elbow.
  2. Skin reaction: After the injection, a small, pale bump (wheal) will appear at the site. This is a normal reaction and will disappear within a few minutes.
  3. Reading: You will need to return to the healthcare facility 48-72 hours after the injection to have the test read. During this second visit, a trained healthcare professional will examine the injection site for signs of a reaction.

What to Expect During the TB Skin Test

During the injection, you may feel a slight sting or burn, but the discomfort should be minimal and brief. After the injection, you may notice some redness, swelling, or itching at the site, but these symptoms should subside within a few days.

It’s important to keep the injection site clean and dry, and to avoid scratching or rubbing the area. You should also avoid applying any creams, lotions, or bandages to the site, as these can interfere with the test results.

Interpreting TB Skin Test Results

A healthcare professional will interpret the TB skin test results based on the size of the induration (hardened area) at the injection site. The induration is measured in millimeters (mm) across the forearm, perpendicular to the long axis.

The interpretation of the test results depends on the individual’s risk factors and medical history. In general:

  • Positive result: An induration of 5 mm or more is considered positive in people with HIV, recent TB contacts, or those with chest X-ray findings suggestive of previous TB. For other high-risk groups, such as healthcare workers or people with weakened immune systems, an induration of 10 mm or more is considered positive. In people with no known risk factors, an induration of 15 mm or more is considered positive.
  • Negative result: If there is no induration or the induration is smaller than the criteria for a positive result, the test is considered negative. This generally means that the person has not been infected with TB bacteria.
  • Indeterminate result: In rare cases, the test may be difficult to interpret due to factors such as improper administration, incorrect reading, or a compromised immune system. In these situations, the test may need to be repeated or additional diagnostic tests may be required.

Dr. Michael Chen, an infectious disease specialist, emphasizes the importance of follow-up testing for positive results: “A positive TB skin test doesn’t necessarily mean that a person has active TB disease. It does, however, indicate that they have been infected with TB bacteria at some point. Additional tests, such as a chest X-ray and sputum culture, are needed to determine if the infection is latent or active. If active TB is confirmed, prompt treatment is essential to prevent the spread of the disease and to ensure the best possible outcome for the patient.”

Limitations of the TB Skin Test

While the TB skin test is a valuable diagnostic tool, it has some limitations that healthcare providers and patients should be aware of:

  1. False-positive results: The TB skin test can sometimes produce false-positive results, particularly in people who have received the BCG vaccine or have been exposed to non-tuberculosis mycobacteria. The BCG vaccine, which is used in many countries to prevent severe forms of TB in children, can cause a positive skin test reaction even in the absence of TB infection.
  2. False-negative results: In some cases, the TB skin test may fail to detect TB infection, resulting in a false-negative result. This can occur in people with weakened immune systems, such as those with HIV or those taking immunosuppressive medications. False-negative results can also occur if the test is administered or read incorrectly.
  3. Booster effect: Some people may have a negative TB skin test result despite having been infected with TB bacteria in the past. This is because their immune system’s ability to react to the tuberculin may have waned over time. In these cases, a second TB skin test administered 1-3 weeks after the first test may trigger a positive reaction, known as the booster effect.
  4. Inability to differentiate between latent and active TB: A positive TB skin test indicates that a person has been infected with TB bacteria, but it cannot distinguish between latent TB infection (LTBI) and active TB disease. Additional tests, such as chest X-rays and sputum cultures, are needed to make this determination.

Despite these limitations, the TB skin test remains an important tool in the global fight against tuberculosis. Healthcare providers must use their clinical judgment and consider each patient’s individual circumstances when interpreting test results and making treatment decisions.

Alternatives to the TB Skin Test

In addition to the TB skin test, there are other diagnostic tests available for detecting TB infection, such as TB blood tests or Interferon Gamma Release Assays (IGRAs).

IGRAs, such as the QuantiFERON-TB Gold and T-SPOT.TB tests, measure the immune system’s response to TB bacteria by analyzing blood samples. These tests have some advantages over the TB skin test:

  1. Single visit: IGRAs require only one blood draw and do not require a return visit for reading, making them more convenient for patients.
  2. No booster effect: IGRAs are not affected by the booster effect, which can cause false-positive results in the absence of TB infection.
  3. No booster effect: IGRAs are not affected by the booster effect, which can cause false-positive results on repeat TB skin testing.
  4. Differentiation between latent and active TB: While IGRAs, like the TB skin test, cannot distinguish between latent and active TB, they may be more specific for detecting latent TB infection in certain populations.

However, IGRAs also have some disadvantages compared to the TB skin test:

  1. Cost: IGRAs are generally more expensive than the TB skin test, which can be a barrier in resource-limited settings.
  2. Laboratory requirements: IGRAs require specialized laboratory equipment and trained personnel, which may not be readily available in all healthcare facilities.
  3. Limited data in certain populations: There is less data on the performance of IGRAs in certain high-risk groups, such as young children and immunocompromised individuals.

The choice between a TB skin test and an IGRA depends on various factors, including the patient’s age, risk factors, BCG vaccination status, and the healthcare setting. In some cases, both tests may be used together to improve the accuracy of TB diagnosis.

Dr. Emily Lee, a pediatric infectious disease specialist, notes, “In children, especially those under 5 years old, the TB skin test is often preferred due to the limited data on IGRA performance in this age group. However, for older children and adults, IGRAs can be a valuable alternative, particularly in BCG-vaccinated individuals or those who may have difficulty returning for the second visit required for the TB skin test.”

Artboard 1 copy 56

Preparing for a TB Skin Test

Before getting a TB skin test, it’s important to inform your healthcare provider about any factors that may affect the test results or your health. Here are some key considerations:

  1. Medical history: Tell your doctor about any allergies, recent illnesses, medications (especially immunosuppressants), or a history of TB exposure or vaccination (BCG).
  2. Pregnancy and breastfeeding: If you are pregnant or breastfeeding, discuss the risks and benefits of the TB skin test with your doctor. In most cases, the test is considered safe during pregnancy and breastfeeding.
  3. Timing: If you need multiple vaccinations or tests, your doctor may recommend spacing them out to avoid potential interference with the TB skin test results.
  4. Clothing: Wear loose-fitting clothing that allows easy access to your forearm for the injection and reading of the test.

On the day of your appointment, inform the healthcare professional administering the test about any concerns or questions you may have. They will provide you with specific instructions on caring for the injection site and when to return for the test reading.

Possible Side Effects of a TB Skin Test

The TB skin test is generally safe and well-tolerated. Most people experience only minor side effects, if any. Common side effects include:

  1. Redness, swelling, or itching at the injection site: These reactions are usually mild and resolve within a few days to a week.
  2. Hardening or bumps at the injection site: A raised, firm area may develop at the injection site, which is a normal part of the immune response to the tuberculin.

Rare side effects may include:

  1. Fever: In some cases, a low-grade fever may occur following the TB skin test.
  2. Allergic reaction: Rarely, a person may experience an allergic reaction to the components of the tuberculin solution, which may cause hives, difficulty breathing, or swelling of the face, lips, or tongue. Seek immediate medical attention if you experience these symptoms.

If you have any concerns about side effects or reactions to the TB skin test, contact your healthcare provider for guidance.

Frequently Asked Questions About TB Skin Tests

Does a TB skin test hurt?

The TB skin test involves a small needle injection under the skin of your forearm. Most people report only minor discomfort, similar to a bug bite or a small pinch. The injection itself is quick, and any pain usually subsides within a few minutes.

How long does a TB skin test take?

The TB skin test is a two-step process. The first visit, when the tuberculin is injected, typically takes only a few minutes. You will then need to return to the healthcare facility 48-72 hours later for the test to be read, which also takes only a few minutes.

What happens if I miss my second appointment for the TB skin test reading?

It’s crucial to return for your second appointment within the 48-72 hour window for accurate test results. If you miss this window, you may need to repeat the entire test process, starting with a new injection.

Can I travel with a positive TB skin test?

A positive TB skin test does not necessarily mean you have active TB disease and are contagious. However, you may need additional tests and clearance from a healthcare provider before traveling. Dr. Michael Chen advises, “If you have a positive TB skin test and are planning to travel, consult your doctor well in advance. They can help determine if you have latent or active TB and provide appropriate treatment or clearance for travel.”

Where can I get a TB skin test?

TB skin tests are available at various healthcare facilities, including:

  • Primary care clinics
  • Public health departments
  • Occupational health clinics
  • Travel clinics
  • Some pharmacies and urgent care centers

Contact your local healthcare provider or public health department to find out where you can get a TB skin test in your area.

Conclusion: Importance of TB Testing

The TB skin test is a valuable tool in the global fight against tuberculosis. By detecting TB infection, healthcare providers can identify individuals who may benefit from preventive treatment, thereby reducing the risk of progression to active TB disease and the spread of the infection to others.

TB skin tests play a crucial role in TB control programs, particularly in high-risk settings such as healthcare facilities, correctional institutions, and shelters. By routinely screening individuals in these settings, public health officials can identify and treat TB infections early, preventing outbreaks and protecting public health.

If you have any questions or concerns about the TB skin test or your individual risk factors for TB, consult a healthcare professional. They can provide personalized guidance and support in understanding and interpreting your test results.

Key Takeaways

  • The TB skin test is a diagnostic tool used to detect TB infection by measuring the immune system’s response to tuberculin.
  • Individuals at increased risk of TB exposure or progression to active TB disease should consider getting a TB skin test.
  • The TB skin test involves a two-visit process: injection of tuberculin and reading of the skin reaction 48-72 hours later.
  • A positive TB skin test indicates TB infection, but additional tests are needed to differentiate between latent and active TB.
  • False-positive results can occur in individuals who have received the BCG vaccine or have been exposed to non-tuberculosis mycobacteria.
  • TB blood tests (IGRAs) are an alternative to the TB skin test, with some advantages and disadvantages.
  • Before getting a TB skin test, inform your healthcare provider about your medical history, allergies, and any medications you are taking.
  • Common side effects of the TB skin test include redness, swelling, and itching at the injection site, which usually resolve within a few days.
  • If you have a positive TB skin test and are planning to travel, consult your doctor well in advance for appropriate evaluation and clearance.
  • TB skin tests are available at various healthcare facilities, including primary care clinics, public health departments, and occupational health clinics.
  • The TB skin test plays a vital role in TB control programs by detecting TB infection and preventing the spread of the disease.

Visit Mirari Doctor for more information on TB testing and other health topics.

References

  1. Centers for Disease Control and Prevention. (2020). Testing for TB Infection. https://www.cdc.gov/tb/topic/testing/tbtesttypes.htm
  2. World Health Organization. (2022). WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis – Rapid diagnostics for tuberculosis detection. https://www.who.int/publications/i/item/9789240030589
  3. Menzies, D., Pai, M., & Comstock, G. (2007). Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Annals of internal medicine, 146(5), 340-354. https://doi.org/10.7326/0003-4819-146-5-200703060-00006
  4. Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K., & Banaei, N. (2014). Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clinical microbiology reviews, 27(1), 3-20. https://doi.org/10.1128/CMR.00034-13
  5. Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L. (2017). Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 64(2), e1-e33. https://doi.org/10.1093/cid/ciw694
  6. Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., Higashi, J. M., Ho, C. S., Hopewell, P. C., Keshavjee, S. A., Lienhardt, C., Menzies, R., Merrifield, C., Narita, M., O’Brien, R., Peloquin, C. A., … Vernon, A. (2016). Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63(7), e147-e195. https://doi.org/10.1093/cid/ciw376
  7. Nayak, S., & Acharjya, B. (2012). Mantoux test and its interpretation. Indian dermatology online journal, 3(1), 2-6. https://doi.org/10.4103/2229-5178.93479
  8. Snider D. E., Jr (1982). The tuberculin skin test. The American review of respiratory disease, 125(3 Pt 2), 108–118. https://doi.org/10.1164/arrd.1982.125.3P2.108
  9. Starke J. R. (2014). Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics, 134(6), e1763–e1773. https://doi.org/10.1542/peds.2014-2983
  10. Farhat, M., Greenaway, C., Pai, M., & Menzies, D. (2006). False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 10(11), 1192–1204.
5/5 - (1 vote)

Related articles



Image
Image

MIRARI®
Cold Plasma System

The world's first handheld cold plasma device

Learn More


Made in USA

Image